Cenra Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Chih-Yung Wu

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	3.9yrs
Eigentum des Geschäftsführers	0.00001%
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	3.8yrs

Jüngste Management Updates

Recent updates

China Chemical & Pharmaceutical's (TWSE:1701) Dividend Will Be Reduced To NT$0.50

Jul 12

Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching

Apr 25

We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt

Apr 07

The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On

Mar 17

China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Feb 24

Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?

Jan 27

Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?

Jan 06

The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On

Dec 16

China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Nov 26

Geschäftsführer

Chih-Yung Wu

3.9yrs

Amtszeit

Mr. Chih-Yung Wu is President and Manager of China Chemical & Pharmaceutical Co., Ltd. since November 5, 2020. Mr. Wu was Technology Director & Vice President of R&D at China Chemical & Pharmaceutical Co.,...

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Hong-So Chen	Independent Director	8.3yrs	keine Daten	keine Daten
Hou-Jie Wang	Representative Director	4.7yrs	keine Daten	3.11% NT$ 186.9m
Yi-Chen Hsieh Wang	Representative Chairman	3.8yrs	keine Daten	1.61% NT$ 96.4m
Dah-Jen Chow	Independent Director	3.3yrs	keine Daten	keine Daten
Chia-Hwel Leu	Independent Director	2.3yrs	keine Daten	keine Daten

3.8yrs

Durchschnittliche Betriebszugehörigkeit

Erfahrener Vorstand: 1701Die Vorstandsmitglieder gelten als erfahren (3.5 Jahre durchschnittliche Amtszeit).

Cenra Management

Management Kriterienprüfungen 1/4

Wichtige Informationen

Jüngste Management Updates

China Chemical & Pharmaceutical Co., Ltd. Announces Cenra Inc Appoints Wang Hsieh, I-Chen as Chairman of the Board of Directors, Effective September 2, 2024

China Chemical & Pharmaceutical Co., Ltd., Annual General Meeting, May 28, 2024

High number of new and inexperienced directors

High number of new and inexperienced directors

Less than half of directors are independent

China Chemical & Pharmaceutical Co., Ltd. Announces Chow,Dah-Jen as Member of Compensation Committee

Recent updates

Second quarter 2024 earnings released: EPS: NT$0.27 (vs NT$0.18 in 2Q 2023)

Now 25% undervalued after recent price drop

China Chemical & Pharmaceutical Co., Ltd. to Report Q2, 2024 Results on Aug 06, 2024

Upcoming dividend of NT$0.50 per share

China Chemical & Pharmaceutical's (TWSE:1701) Dividend Will Be Reduced To NT$0.50

Dividend reduced to NT$0.50

China Chemical & Pharmaceutical Co., Ltd. Announces Cenra Inc Appoints Wang Hsieh, I-Chen as Chairman of the Board of Directors, Effective September 2, 2024

First quarter 2024 earnings released: EPS: NT$0.36 (vs NT$0.34 in 1Q 2023)

China Chemical & Pharmaceutical Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

China Chemical & Pharmaceutical Co., Ltd. to Report Q1, 2024 Results on May 09, 2024

Full year 2023 earnings released: EPS: NT$1.08 (vs NT$1.61 in FY 2022)

China Chemical & Pharmaceutical Co., Ltd. Proposes Dividend Distribution for the Year Ended December 31, 2023

China Chemical & Pharmaceutical Co., Ltd., Annual General Meeting, May 28, 2024

New minor risk - Profit margin trend

Second quarter 2023 earnings released: EPS: NT$0.18 (vs NT$0.52 in 2Q 2022)

Upcoming dividend of NT$0.80 per share at 3.2% yield

China Chemical & Pharmaceutical Co., Ltd. Approves Cash Dividend, Payable on August 22, 2023

Investor sentiment improved over the past week

Investor sentiment improved over the past week

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: NT$0.43 (vs NT$0.43 in 3Q 2021)

Second quarter 2022 earnings released: EPS: NT$0.52 (vs NT$0.35 in 2Q 2021)

Upcoming dividend of NT$0.90 per share

China Chemical & Pharmaceutical Co., Ltd. Announces Cash Dividends to Shareholders, Payable on August 19, 2022

High number of new and inexperienced directors

China Chemical & Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021

First quarter 2022 earnings released: EPS: NT$0.30 (vs NT$0.43 in 1Q 2021)

Less than half of directors are independent

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS: NT$1.74 (vs NT$1.88 in FY 2020)

China Chemical & Pharmaceutical Co., Ltd. Announces Cash Dividend for the Year Ended December 31, 2021

Third quarter 2021 earnings released: EPS NT$0.43 (vs NT$0.40 in 3Q 2020)

Second quarter 2021 earnings released: EPS NT$0.35 (vs NT$0.78 in 2Q 2020)

Upcoming dividend of NT$1.00 per share

First quarter 2021 earnings released: EPS NT$0.43 (vs NT$0.38 in 1Q 2020)

Here's Why We Think China Chemical & Pharmaceutical (TPE:1701) Is Well Worth Watching

We Think China Chemical & Pharmaceutical (TPE:1701) Can Stay On Top Of Its Debt

Full year 2020 earnings released: EPS NT$1.88 (vs NT$1.29 in FY 2019)

The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 34% And Shareholders Are Holding On

China Chemical & Pharmaceutical Co., Ltd.'s (TPE:1701) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Is China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) A Good Fit For Your Dividend Portfolio?

New 90-day low: NT$22.50

Does China Chemical & Pharmaceutical (TPE:1701) Have A Healthy Balance Sheet?

New 90-day high: NT$23.80

The China Chemical & Pharmaceutical (TPE:1701) Share Price Is Up 22% And Shareholders Are Holding On

China Chemical & Pharmaceutical Co., Ltd. (TPE:1701) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Third quarter 2020 earnings released: EPS NT$0.39

China Chemical & Pharmaceutical Co., Ltd. Announces Chow,Dah-Jen as Member of Compensation Committee

China Chemical & Pharmaceutical Co., Ltd. Announces Executive Changes

First half earnings released

Geschäftsführer

Amtszeit

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit